Skip to main content

Table 2 The overlap between CA125-positive samples (cut-off > 35 IU/mL) and the three DNAme marker panel (using refined new thresholds, see Table 1) in HGS cancer cases and healthy (H)/benign pelvic mass (BPM) controls in serum set 3

From: The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer

  H and BPM HGS
CA125-negative CA125-positive CA125-negative CA125-positive
3 DNAme marker panel (new thresholds) Negative 108 18 4 9
Positive 14 0 1 15